ATE311392T1 - Verbindungen und methoden zur inhibierung von mrp1 - Google Patents

Verbindungen und methoden zur inhibierung von mrp1

Info

Publication number
ATE311392T1
ATE311392T1 AT02728409T AT02728409T ATE311392T1 AT E311392 T1 ATE311392 T1 AT E311392T1 AT 02728409 T AT02728409 T AT 02728409T AT 02728409 T AT02728409 T AT 02728409T AT E311392 T1 ATE311392 T1 AT E311392T1
Authority
AT
Austria
Prior art keywords
compounds
methods
mrp1
inhibiting mrp1
inhibiting
Prior art date
Application number
AT02728409T
Other languages
English (en)
Inventor
Rosanne Bonjouklian
Louis Nickolaus Jungheim
Kenneth Jeff Thrasher
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE311392T1 publication Critical patent/ATE311392T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02728409T 2001-04-09 2002-03-28 Verbindungen und methoden zur inhibierung von mrp1 ATE311392T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28264101P 2001-04-09 2001-04-09
PCT/US2002/006668 WO2002081482A1 (en) 2001-04-09 2002-03-28 Compounds and methods for inhibiting mrp1

Publications (1)

Publication Number Publication Date
ATE311392T1 true ATE311392T1 (de) 2005-12-15

Family

ID=23082441

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02728409T ATE311392T1 (de) 2001-04-09 2002-03-28 Verbindungen und methoden zur inhibierung von mrp1

Country Status (7)

Country Link
US (1) US7037921B2 (de)
EP (1) EP1392702B1 (de)
JP (1) JP2004529920A (de)
AT (1) ATE311392T1 (de)
CA (1) CA2442530A1 (de)
DE (1) DE60207709T2 (de)
WO (1) WO2002081482A1 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL343313A1 (en) 1998-04-08 2001-08-13 Lilly Co Eli Methods for inhibiting mrp1
CN1296408A (zh) 1998-04-08 2001-05-23 伊莱利利公司 抑制mrp1的方法

Also Published As

Publication number Publication date
US20040097507A1 (en) 2004-05-20
DE60207709T2 (de) 2006-07-20
EP1392702A1 (de) 2004-03-03
DE60207709D1 (de) 2006-01-05
US7037921B2 (en) 2006-05-02
CA2442530A1 (en) 2002-10-17
JP2004529920A (ja) 2004-09-30
WO2002081482A1 (en) 2002-10-17
EP1392702B1 (de) 2005-11-30

Similar Documents

Publication Publication Date Title
ATE316531T1 (de) Kondensierte dihydrochinolinon-derivate zur hemmung von mrp1
DE60234510D1 (de) 1h-indazolverbindungen die jnk hemmen
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
MY141255A (en) Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
NO20065178L (no) Tienopyridinderivater
BRPI0417543A (pt) quinolinas úteis no tratamento de doença cardiovascular
CY1108409T1 (el) Υβριδικα αντιβιοτικα οξαζολιδινονης-κινολονης
PL369530A1 (en) Chemical compounds
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
NO20073801L (no) Atineoplastiske kombinasjoner
ATE425983T1 (de) Siloxy substituierte metallocenkatalysatoren
AR057914A1 (es) Compuestos organicos de azufre y su uso
CY1108567T1 (el) Αντιθρομβωτικες ενωσεις
WO2004069793A3 (en) Novel 2-substituted cyclic amines as calcium sensing receptor modulators
ATE452882T1 (de) Herstellung von quetiapin
ATE342896T1 (de) Fluoreszierende proben zur quantitativen bestimmung von zink
ATE291024T1 (de) Neue 4-aminofuropyrimidine und ihre verwendung
DE602005027213D1 (de) Neue imidazolidinderivate
ATE411287T1 (de) Neue metallproteinaseinhibitoren
DE602004005881D1 (de) Substituierte pyrazinonverbindungen zur behandlung von entzündungen
NO20062062L (no) Procsesser for preparering av forskjellige former for (S)-(+)-clopidogrel bisulfat
ATE516031T1 (de) Verbindungen gegen krebs
BR0115996A (pt) Sulfamidotienopirimidinas
TR200002851T2 (tr) MRP1'i inhibe etmek için yöntemler.
DE60207709D1 (de) Verbindungen und methoden zur inhibierung von mrp1

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties